In DTC healthcare advertising, even well-targeted audience pools contain significant noise. PulsePoint’s Adaptive Optimization™ addresses this directly.
It is an AI-driven bidding engine that dynamically shifts spend toward the most clinically relevant audience, reducing waste and improving efficiency without manual intervention.
Butler/Till set out to test whether PulsePoint’s Adaptive Optimization™ could meaningfully outperform a standard DTC programmatic control.

![]()
Butler/Till ran two identical tactics within an active DTC campaign from September 2025 through December 2025.
One tactic with Adaptive Optimization™ applied, one tactic without. The agency used IQVIA, a third-party measurement partner, to track performance of Adaptive Optimization™ across several key metrics, including spend per target, average frequency and Audience Quality Index.
Together, these metrics help marketers know if the campaign is spending efficiently, reaching the right patients often enough and improving the clinical quality of its audience over time.

Adaptive Optimization™ delivered on all fronts: efficiency, frequency, and clinical audience quality.
During the first month of the head-to-head test, Adaptive Optimization™ delivered

better cost efficiency than the control tactic.
Performance was strong enough that the non-Adaptive Optimization tactic was paused mid-flight. After the pause, Adaptive Optimization continued to improve, widening the gap to 16.7% total cost efficiency gains...
Create your FREE account to continue reading and explore more expert insights on Pharma Media.
✅ Free. Fast. No commitment.